Author:
Li Chao,Chen Lu,Li Lixian,Chen Wanyi
Reference47 articles.
1. Frailty and the management of hematologic malignancies;Abel;Blood,2018
2. Overview of drug-drug interactions between ritonavir-boosted nirmatrelvir (paxlovid) and targeted therapy and supportive care for lung cancer;Anwar;JTO Clin. Res. Rep.,2022
3. Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results;Byrd;Blood,2020
4. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9);Cesaro;Leukemia,2022
5. Use of modeling and simulation to predict the influence of triazole antifungal agents on the pharmacokinetics of zanubrutinib and acalabrutinib;Chen;Front. Pharmacol.,2022
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献